Research use only · third-party COA for every lot support@retatrutide-peptide.info
Retatrutide-Peptide.info

Store

Order retatrutideBasketLab reportsWholesale

Start here

About retatrutideBenefitsResultsReviewsFDA status

Protocols

Dosage chartCalculatorReconstitutionInjectionHalf-lifeStacks

Safety

Side effectsFor womenBlood sugarMuscle

Compare

vs Tirzepatidevs Semaglutidevs other GLP-1s

Buying

Where to buyPriceCompoundedVendorsOral form

Company

About usReview boardContent standardsSourcesHelp
Author

Eric J. Topol, MD

A cardiologist and geneticist who serves as Executive Vice-President of Scripps Research and ranks among the ten most frequently cited researchers in medicine.

Eric J. Topol, MD

Author

A cardiologist and geneticist by training, he holds the title of Executive Vice-President at Scripps Research, sits at the helm of Medscape as Editor-in-Chief, and is counted among medicine's ten most-cited researchers.

Education and training

CredentialInstitutionYear
BA, Biomedicine (highest distinction)University of Virginia1975
MDSchool of Medicine, University of Rochester1979
Residency, Internal MedicineUniversity of California, San Francisco1979-1982
Fellowship, CardiologyJohns Hopkins University1982-1985

Current positions

  • Director of the Department of Translational Medicine at Scripps Research
  • Executive Vice-President, Scripps Research
  • Founder and Director of the Scripps Research Translational Institute, which he built and continues to lead
  • Holder of the Gary and Mary West Chair of Innovative Medicine
  • Professor of Molecular Medicine
  • Serves as a Senior Consultant within the Division of Cardiovascular Diseases at Scripps Clinic
  • Editor-in-Chief, Medscape

Scientific standing

Author of over 1,300 peer-reviewed publications with more than 400,000 citations and an h-index of 259. Elected to the National Academy of Medicine (2004), the American Society for Clinical Investigation, the Association of American Physicians, and the Johns Hopkins Society of Scholars.

Played a key role in creating t-PA, Plavix (clopidogrel), Angiomax (bivalrudin), and ReoPro (abciximab). Oversaw clinical trials enrolling over 200,000 patients across more than 40 countries, most notably the GUSTO series.

Research areas

His research spans aging and longevity, genetics and genomics, heart disease, pharmacogenomics, digital medicine, artificial intelligence in healthcare, and individualised or precision medicine.

Books

  • Super Agers: An Evidence-Based Approach to Longevity (2025), New York Times bestseller
  • Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again (2019)
  • The Patient Will See You Now (2015)
  • The Creative Destruction of Medicine (2012)

Awards

Included in the inaugural TIME100 Health list (2024) U.S. News & World Report Best Leaders 2025, alongside the Simon Dack Award (ACC), Andreas Gruentzig Award (ESC), Doctor of the Decade (ISI), and the Hutchinson Medal (University of Rochester).

Profiles and links

Retatrutide vial
Retatrutide
Research-grade · COA per lot
$125.00

Retatrutide vial
Retatrutide98%+ purity · third-party tested
$125.00